from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3169/-

LFCtreatmentdescriptionclass of inhibitor

-0.095

Amikacinug/mL Amikacintranslation

-0.787

Cap5-10ug/mL Capreomycintranslation

-0.394

Rox10-50 ug/mL Roxithromycintranslation

0.286

SM2-5 ug/mL Streptomycintranslation

0.558

Tet5-10 ug/mL Tetracyclinetranslation

1.402

Rif0.2-5ug/mL Rifampicintranscription

0.268

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.022

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.330

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.354

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.365

Clofazimine10-13 ug/mL Clofaziminerespiration

0.017

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.617

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.842

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.610

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.423

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.969

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.665

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.069

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.339

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.977

KCN5-20 ug/mL Potassium cyaniderespiration

-0.681

NaN30.2-2 mM Sodium aziderespiration

-0.074

Nigericin50 uM Nigericinrespiration

0.311

TRC10-150 ug/mL Triclosanrespiration

-0.202

TRZ10-25 ug/mL Thioridazinerespiration

-0.760

Valinomycin0.5-10 uM Valinomycinrespiration

-0.269

ZnSO42 mM ZnSO4respiration

-0.643

menadione6-10 ug/mL Menadionerespiration

3.098

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.450

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.538

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.181

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.563

NRP_1Non-replicating persistence stage 1dosRassociated

0.082

Amp0.2mg/mL AmpicillincellWall

-0.132

Cephalexin20-100 ug/mL CephalexincellWall

0.116

Cerulenin0.32-5 ug/mL CerulenincellWall

0.481

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.238

EMB10-20 ug/mL EthambutolcellWall

0.171

Eta12-40 ug/mL EthionamidecellWall

0.078

INH0.2-0.4 ug/mL IsoniazidcellWall

0.035

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.891

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.435

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.242

BZA0.12 mg/mL BenzamidearomaticAmides

-0.150

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.162

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.219

H2O24 mM hydrogen peroxideDNAdamaging

0.363

Levo10 ug/mL LevofloxacinDNAdamaging

-0.196

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-3.105

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.466

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.401

UVUV-irradiationDNAdamaging

0.954

ARP41-4 ug/mL Antitubercular compound ARP4?

0.743

Antimycin12.5-50 ug/mL Antimycin A?

0.635

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.968

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.224

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.463

PA8240.2-2 ug/mL PA-824?

-1.291

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.118

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.430

Verapamil50 uM Verapamil?

0.251

mercaptoethanol2 mM 2-Mercaptoethanol?

0.487

methoxatin10-20 ug/mL Methoxatin?